["The Lantus case": and yet it does move (or not?)].
Schöffski
O
O
Friedrich-Alexander-Universität Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement, Lange Gasse 20, 90403 Nürnberg. oliver.schoeffski@wiso.uni-erlangen.de
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D005858:Germany; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics* / Q000627:therapeutic use; D007328:Insulin / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting
D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine